Iopanoic Acid

Summary

Iopanoic Acid (CHEMBL867) is an approved small molecule (ATC V08AC06).

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• ATC class: V08AC06
• Chemistry: 570.93 Da · C11H12I3NO2

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL867
Name	Iopanoic Acid
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	3735
ATC	V08AC06
Molecular formula	C11H12I3NO2
Molecular weight	570.93
InChIKey	OIRFJRBSRORBCM-UHFFFAOYSA-N

SMILES: CCC(CC1=C(C(=C(C=C1I)I)N)I)C(=O)O

IUPAC name: 2-[(3-amino-2,4,6-triiodophenyl)methyl]butanoic acid

Also known as: Acide iopanoique, Acido iopanoico, Acidum iopanoicum, Bilijodon, Choladine, Cholevid, Cistobil, Colepax, Copanoic, Iopagnost, Iopanoate, Iopanoic acid

Patent coverage: 950 distinct patent families (3,268 SureChEMBL compound mentions), from 2 matched compound structure(s). One matched structure accounts for 3,226 (99%) of the total. Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

Broader ChEMBL bioactivity targets: 4 (assay-derived). Sample: Thromboxane A2 receptor, Muscarinic acetylcholine receptor M1, Alpha-1A adrenergic receptor, 3’,5’-cyclic-AMP phosphodiesterase 4A.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).